Multi-Drug Resistant (MDR) TB Patient Costing Tool
Multi-Drug Resistant (MDR) TB patients incur significant costs for seeking and undergoing treatment. It is important to understand these costs to develop appropriate levels of social protection to prevent people from deciding not to seek diagnosis or discontinuing treatment, or from suffering economic hardship as a result of treatment.
The tool is comprised of a questionnaire and user manual and a guide for the analysis of the results. It is designed to be used by TB Program Managers at national and sub-national levels. The tool has been developed by KNCV and MSH for USAID’s TB CARE Project and should be available shortly.
Management Sciences for Health
784 Memorial Drive
Cambridge, MA 02139